Immuvera Therapeutics AS

926 109 553 ↗Other technical consultancy
identity
AS · est 2020OsloParent · 1 subsidiarywas ALV B AS →2025
Brreg · companies
Employees
CEO · since2025-03-13Jørund Sollid
Chair · since2026-07-08Marcus Sahlin Pettersen
headcount series appears after two register changes
Roles from Brreg, shown for business contact only. No birth date is shown or exported (purpose limitation, GDPR Art. 6(1)(f)).
Brreg · company_people
5 registered roles
Daglig lederJørund Sollid2025-03-13
Styrets lederMarcus Sahlin Pettersen Multiple boards2026-07-08
StyremedlemKristin Malene Bjerke Multiple boards2026-07-08
StyremedlemBenedicte Heidenreich Fossum Multiple boards Serial CEO2026-07-08
StyremedlemJostein Christian Dalland Multiple boards2026-07-08
NOK, amounts in thousands
20242025
Revenue220
Operating result−5 909
Result before tax−5 918
Net result−5 918
Total assets20 556
Equity15 817
202020212022202320242025
Revenue220
Operating result−5 909
Result before tax−5 918
Net result−5 918
Total assets20 556
Equity15 817
Regnskapsregisteret · company_revenue · FY2024 (company)
register ledger · money
2026-08-06regaccounts_filed: last_annual_accounts_year2024 -> 2025
2021-12-31own+OSLO KAPITALFORVALTNING AS acquired 9.9 pct
20242025
ALV AS 4032
AMBROSIA AS 64
OSLO KAPITALFORVALTNING AS 22
ESTER 4.14 AS 88
BILJANA STANGELAND HOLDING AS
GANDALF AS 53
NISTADGRUPPEN AS 5
IMMUVERA THERAPEUTICS AS · self00
POLAR PRODUCTION AS 22
C. EMTOR EIENDOM AS 11
+ 134 smaller holders
202020212022202320242025
ALV AS 1005345404032
AMBROSIA AS 108664
OSLO KAPITALFORVALTNING AS 107222
ESTER 4.14 AS 888
BILJANA STANGELAND HOLDING AS 8
GANDALF AS 86553
NISTADGRUPPEN AS 5
IMMUVERA THERAPEUTICS AS · self4000
POLAR PRODUCTION AS 22
C. EMTOR EIENDOM AS 22111
+ 134 smaller holders
Aksjonærregisteret · company_ownership · 2025 · both directions
register ledger · owners
2023-12-31own+ESTER 4.14 AS acquired 8.3 pct
2022-12-31own−BILJANA STANGELAND HOLDING AS exited (held 7.7 pct)
2021-12-31own+GANDALF AS acquired 7.7 pct
2021-12-31own+BILJANA STANGELAND HOLDING AS acquired 7.7 pct
2021-12-31own+AMBROSIA AS acquired 9.9 pct
2021-12-31own+OSLO KAPITALFORVALTNING AS acquired 9.9 pct
stewards
202420252026
auditor
accountant FIRST ACCOUNTING AS 2022-02-17
2020202120222023202420252026
auditor
accountant FIRST ACCOUNTING AS 2022-02-17
Brreg · company_org_roles
tenders
No recorded tender wins.
Relevant open tenders — matched · NACE 71.129 ↔ CPV
subscribers sharpen matches with per-company keywords
open-tender matching (NACE ↔ CPV) awaits Intelligo's open-tenders view
Doffin/TED · company_tender_wins · 2026-08-14
hiring
No job ads on record in the last 12 months.
NAV Arbeidsplassen · company_job_ad_months
group · owns
Group revenue kr 220kGroup net kr -5.92MTenders won 0Rolled up across the parent + 1 subsidiary — 930042692 alone is —.
rollup estimate · filed konsernregnskap not yet in Intelligo
99%
Immuvera Therapeutics AS 0.2%
Aksjonærregisteret · company_ownership · 2025 · both directions
report
This company's annual report has not been read yet. The filed figures above come from the accounts form; everything the board wrote around them is in the PDF, which is read on request.
Regnskapsregisteret (årsberetning) · company_annual_reports
register
registered 2020-12-05
Brreg · companies
register ledger · 8 events
2026-08-10regaudit_opt_out: audit_opt_out_date2020-12-05
2026-08-06regaccounts_filed: last_annual_accounts_year2024 -> 2025
2023-12-31own+ESTER 4.14 AS acquired 8.3 pct
2022-12-31own−BILJANA STANGELAND HOLDING AS exited (held 7.7 pct)
2021-12-31own+GANDALF AS acquired 7.7 pct
2021-12-31own+BILJANA STANGELAND HOLDING AS acquired 7.7 pct
2021-12-31own+AMBROSIA AS acquired 9.9 pct
2021-12-31own+OSLO KAPITALFORVALTNING AS acquired 9.9 pct
Skiwo · company_events